Abstract:Parkinson's disease is a chronic neuropathy characterised by the formation of Lewy bodies (misfolded alpha-synuclein) in dopaminergic neurons of the substantia nigra and other parts of the brain. Dopaminergic neurons play a vital role in generating both motor and non-motor symptoms. Finding therapeutic targets for Parkinson's disease (PD) is hindered due to an incomplete understanding of the disease's pathophysiology. Existing evidence suggests that the gut microbiota participates in the pathogenesis of PD via immunological, neuroendocrine, and direct neural mechanisms. Gut microbial dysbiosis triggers the loss of dopaminergic neurons via mitochondrial dysfunction. Gut dysbiosis triggers bacterial overgrowth in the small intestine, which increases the permeability barrier and induces systemic inflammation. It results in excessive stimulation of the innate immune system. In addition to that, activation of enteric neurons and enteric glial cells initiates the aggregation of alpha-synuclein. This alpha-synucleinopathy thus affects all levels of the brain-gut axis, including the central, autonomic, and enteric nervous systems. Though the neurobiological signaling cascade between the gut microbiome and the central nervous system is poorly understood, gut microbial metabolites may serve as a promising therapeutic strategy for PD. This article summarises all the known possible ways of bidirectional signal communication, i.e., the "gut-brain axis," where microbes from the middle gut interact with the brain and vice versa, and highlights a unique way to treat neurodegenerative diseases by maintaining homeostasis. The tenth cranial nerve (vagus nerve) plays a significant part in this signal communication. However, the leading regulatory factor for this axis is a diet that helps with microbial colonisation and brain function. Short-chain fatty acids (SCFAs), derived from microbially fermented dietary fibres, link host nutrition to maintain intestinal homeostasis. In addition to that, probiotics modulate cognitive function and the metabolic and behavioural conditions of the body. As technology advances, new techniques will emerge to study the tie-up between gut microbes and neuronal diseases.

The Pivotal Role of Microbiota in Modulating the Neuronal-Glial-Epithelial Unit

Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders

Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

The function of gut microbiota in immune-related neurological disorders: a review

The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic

Interactions between the microbiota and enteric nervous system during gut-brain disorders

The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease

Gut Microbiota: the Brain Peacekeeper.

The Microbiota-Gut-Brain Axis as a Key to Neuropsychiatric Disorders: A Mini Review

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease

Microbiota-gut-brain axis in health and neurological disease: Interactions between gut microbiota and the nervous system

Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases

Gut microbiota: a new insight into neurological diseases

Neuroimmune Connectomes in the Gut and Their Implications in Parkinson's Disease

Microbiota–gut–brain axis: interplay between microbiota, barrier function and lymphatic system

Multidirectional associations between the gut microbiota and Parkinson's disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway

Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders

Impact of gut-brain interaction in emerging neurological disorders

Microbiota-gut-brain axis and the central nervous system